|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash from operating activities: | |||||
| Amortization of deferred implementation, solution and other costs | |||||
| Depreciation and amortization | |||||
| Amortization of debt issuance costs | |||||
| Amortization of debt discount | |||||
| Amortization of premiums and discounts on investments | |||||
| Stock-based compensation expense | |||||
| Realized loss on investments | |||||
| Deferred income taxes | |||||
| Allowance for credit losses | |||||
| Allowance for sales credits | |||||
| Loss on disposal of long-lived assets | |||||
| Loss on extinguishment of debt | |||||
| Gain on extinguishment of debt | |||||
| Lease impairments | |||||
| Other non-cash items | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Prepaid expenses and other current assets | |||||
| Deferred solution and other costs | |||||
| Deferred implementation costs | |||||
| Contract assets, net | |||||
| Other long-term assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Deferred revenues | |||||
| Deferred rent and other long-term liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of investments | |||||
| Maturities of investments | |||||
| Purchases of property and equipment | |||||
| Capitalized software development costs | |||||
| Business combinations, net of cash acquired | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Repurchases of common shares | |||||
| Payment for maturity of convertible notes | |||||
| Payment for repurchases of convertible notes | |||||
| Proceeds from bond hedges related to convertible notes | |||||
| Payments for warrants related to convertible notes | |||||
| Proceeds from capped calls related to convertible notes | |||||
| Debt issuance costs related to revolving credit agreement | |||||
| Proceeds from exercise of stock options and ESPP | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for taxes, net of refund | |||||
| Cash paid for interest | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Shares acquired to settle the exercise of stock options | |||||
| Stock-based compensation for capitalized software development | |||||
| Capitalized software development costs included in accounts payable and accrued liabilities | |||||
| Property and equipment acquired and included in accounts payable and accrued liabilities | |||||
| Property and equipment acquired through tenant improvement allowance | |||||
Loading...